Ats Corporation · TSX:ATS
Ats — Q1 2025 Earnings Presentation
14 slides from Ats's earnings presentation, Aug 8, 2024
Slide 1: Q1 2025 Earnings Call
Q1 2025 Earnings Call August 8, 2024 8:30am ET
Slide 2: Today's Hosts
Today's Hosts Andrew Hider Ryan McLeod Chief Executive Officer Chief Financial Officer Note to Reader: This presentation and the oral statements made during this call contain certain statements that may constitute forward-looking information and forward-looking statements within the meaning of appli
Slide 3: Non-IFRS and Other Financial Measures
Non-IFRS and Other Financial Measures Throughout this presentation management uses certain non-IFRS financial measures, non-IFRS ratios and supplementary financial measures to evaluate the performance of the Company. The terms “EBITDA”, “organic revenue”, “adjusted net income”, “adjusted earnings fr
Slide 4: Q1 2025 & Recent Highlights
Q1 2025 & Recent Highlights Second strongest Order bookings1 quarter on record, led by life sciences ▪ Q1 Order Bookings¹ up ~18% y/y to $817MM ▪ Q1 Revenues down ~8% y/y to $694.3MM ▪ Q1 Adj. Earnings from Operations¹ of $86.2 million, 12.4% adjusted earnings from operations margin¹ ▪ Order Backlog
Slide 5: Outlook
Outlook Order Backlog1 provides good revenue visibility: • Life Sciences $990MM: funnel remains strong, supported by market growth in key areas • Food and Beverage $216MM: funnel remains strong; Paxiom to complement existing business • Energy $109MM: funnel remains strong and includes longer-term op
Slide 6: Financial Results
Financial Results Y/Y Y/Y (C$ mm, except per share Q1 Q1 Change Change data) F2025 F2024 ($) (%) Revenues $694.3 $753.6 $(59.3) (7.9)% Revenue Growth: Y/Y Q1 Earnings from operations 67.6 79.0 (11.4) (14.4)% Organic1 (12.7)% Adjusted earnings from Acquisitions 4.0 % 86.2 102.1 (15.9) (15.6)% operati
Slide 7: Summary
Summary ▪ Strong, diversified Order Bookings1, and earnings in line with expectations ▪ Estimated Q2-F25 Order Backlog-to-revenue conversion 33% to 36% ▪ Long-term outlook in strategic end-markets remains positive, despite short-term revenue and margin pressures in transportation-related businesses
Slide 8: ATS
ATS
Slide 9: WATS
WATS
Slide 10: Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures
Appendix Reconciliation of Non-IFRS Measures to IFRS Measures 10
Slide 11: Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures
Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures The following table reconciles adjusted EBITDA and EBITDA to the most directly The following table reconciles organic revenue to the most directly comparable IFRS comparable IFRS measure (net income) (in millions of dollars): measure (re
Slide 12: Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures
Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures The following table reconciles adjusted earnings from operations to the most The following table reconciles adjusted basic earnings per share to the most directly comparable IFRS measures (net income) (in millions of dollars): directly c
Slide 13: Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures
Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures The following table reconciles net debt to adjusted EBITDA to the most directly The following table reconciles free cash flow to the most directly comparable comparable IFRS measure (in millions of dollars): IFRS measure (in millions of
Slide 14: Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures
Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures The following table reconciles the previously reported non-IFRS financial measures to reflect the exclusion of the stock-based compensation revaluation expenses: (C$ mm) Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 F2022 F2023 F2023 F2024 F2024 F2024 F2024 F
ATS Corporation Common Shares — Q1 2025 Earnings Presentation on 6ix